Categories
Global Investment

Insilico Medicine Raises $255 Million in Series C Financing Led by Warburg Pincus

Insilico Medicine, an end-to-end artificial intelligence for target discovery, small molecule chemistry, and clinical development company, has announced that it has closed a $255 million Series C financing led by Warburg Pincus. The financing was also participated by current investors including Qiming Venture Partners, Pavilion Capital, Eight Roads Ventures, Lilly Asia Ventures, Sinovation Ventures, BOLD […]

Categories
Executive Movements

Pharma major Lupin appoints Mark D. McDade as Independent Director

Lupin Limited (Lupin), global pharmaceutical company, announced the appointment of Mark D. McDade as an Independent Director effective January 28, 2021.  McDade is the co-Founder and Partner at Qiming Venture Partners, USA where he led several high-value investments in biotherapeutics, including cell and gene therapy and digital health. With a career spanning over 37 years, […]